Blue Horseshoe Stocks: BBRY Recap, AEMD & More

Blackberry Ltd. BBRY – Options Review

We were very confident in the options ideas we formulated for BBRY in yesterday’s premarket report, which were the BBRY Weekly $9.50 & $10 Calls.  We pointed to the company’s convincing earnings beat as being the reason we felt a solid move was in order, despite the fact that it had just been hanging around the $9 area without a lot of volatility for the preceding few weeks.

A solid move is exactly what we got, with BBRY stock running from 9.78 to 10.83 on the day. That facilitated some fantastic gain opportunities for anyone who was following along with our ideas, which both produced multi-bag intraday upswings.

The $9.50 Calls traded in a range from .37-1.26 for a gain of 240%, while the $10′s ripped extremely hard from a low of .12 all the way up to .76. That worked out to an increase of 533% marking the second consecutive week where we’ve alerted on an options idea and seen a single-session gain of over 500% (KMX, last Friday).

Important Note: Never trade options with a weekly expiration on a Friday unless you’re an expert trader with disposable funds. It’s extremely risky.


Aethlon Medical, Inc. AEMD

The other top performer from yesterday’s premarket newsletter was AEMD, which, as you can see from the included chart snapshot, we alerted at the absolute perfect time. The stock had practically been in free-fall over the past couple of weeks, and we signaled the bottom with precision.

It traded in a range from 1.18 to 1.70, for a respectable intraday increase of 44% and closed at the high of day. This is a stock that was trading at nearly $4 just this month, and now we’re going to be monitoring to see how much of that ground it can recapture on the rebound. We’ll look for it to establish higher highs and higher lows. If it can manage to crack through the channel between the current 50DMA of 1.75 and September 11th’s swing high of 2.00, things could once again get very interesting for AEMD.


Extended Watchlist:
HMNY, VERI, ADHD, CONN, ZYNE, VKTX, DOLV

Blue Horseshoe Stocks: Options Roundup & More

Options Roundup

We had good fortune with our fresh options call yesterday, so today we’re going to be recapping the total possible gains on those plays, as well as unearthing a couple of fresh ideas to add to the mix as we close out this trading week.

Delta Air Lines, Inc. DAL – Recap - Our inkling on DAL yesterday morning was to go bearish after a disappointing earnings call for the airline, with the DAL Weekly $55.50-53.50 Puts. We were not disappointed with our decision to do so, as those DAL puts went on to log the following double and multi-bag intraday moves for us before lunch hour was over:

$55.50 Puts – Range: .76-1.60 – Max Gain: 110%
$55 Puts – Range: .48-1.05 – Max Gain: 119%
$54.50 Puts – Range: .25-.65 – Max Gain: 160%
$54 Puts – Range: .13-.36 – Max Gain: 177%
$53.50 Calls – Range: .03-.17 – Max Gain: 466%
______

Advanced Micro Devices Inc. AMD

Speaking of bearish options ideas, we want to enter another fresh set into the log this morning in AMD. This stock trades very cyclically, and from a technical perspective, looks as if it could continue to lose ground after a reversal this week. We’re going to place the AMD 07/21 $14-13 Puts on watch into next week in the event that our impression of this play is correct.
______

BJ’s Restaurants, Inc. BJRI

Lastly on the options front, we are going to signal a range of extended-term calls on BJRI, which has a pretty attractive bottom setup on the chart at the moment. To take advantage of a potential sustained rebound, we’re going to be monitoring the BJRI 08/18 $35 & 40 Calls.
_____

Bonus Idea: NTNX 7/21 $20-25 Calls


Diana Containerships. Inc. DCIX

DCIX went into a full-on nose dive recently after it was announced that the company would be taking out roughly an $85M loan to settle a monster pile of debt, and the investment community did not take the news well.

The stock has subsequently fallen to new all-time lows, and that’s where we come in. We’re always looking for stocks like this to put on bottom-watch. Being egregiously oversold, DCIX may yet have a bit further to fall, but we’ll want to be ready for a reversal at any time. The resulting bounce-back could be considerable.


Extended Watchlist:
NPHC, DEWM, DOLV, FRO, JCP, CHFS, PIXY, HPJ, CTIC,

Blue Horseshoe Stocks: Options, Bottom-Plays & More

Dollar General Corp. DG – Recap

After a beat on sales and profits for the quarter and a chart primed for a bullish move, we highlighted the DG Weekly $75-78 Calls and we’re happy to report that each and every one of the contracts contained within that range recorded huge intraday moves for us.

Regardless which set of the seven was chosen, multi-bag gains were there for the taking:

$75 Calls – Range: .92-3.10 – Max Gain: 237%
$75.50 Calls – Range: .64-.2.22 – Max Gain: 247%
$76 Calls – Range: .40-2.05 – Max Gain: 412%
$76.50 Calls – Range: .24-1.20 – Max Gain: 400%
$77 Calls – Range: .12-1.21 – Max Gain: 908%
$77.50 Calls – Range: .06-.80 – Max Gain: 1233%
$78 Calls – Range: .05-.45 – Max Gain: 800%

_______

Lululemon Athletica LULU – Fresh Ideas

Lululemon had an earnings beat of its own yesterday post-market, so we want to formulate some ideas for the LULU chain as well.

Not only is the stock gapping up on earnings, but like DG yesterday, the LULU chart was already looking like a bottom-play with premium potential. That’s why we want to formulate both a short and long term set of ideas for LULU options. The LULU Weekly $55-57.50 Calls*, to coincide with the immediate boost in activity off of these earnings, and the LULU 06/30 58.50-60.50 Calls in the event of a protracted recovery.

*We never highlight options with a weekly expiration on a Friday without an explicit warning. That should tell you how risky it can be. So if you’re not an expert trader, don’t even think about it!


Synergy Pharmaceuticals, Inc. SGYP

We also want to put SGYP on watch today after noticing that the stock is coming off of its 52-week lows. That’s always a chart setup that we’re going to look at, but in this case the lows followed shartly after the company producing positive Phase III data on its TRULANCE™ drug, which is already approved by the FDA.

We’ve included a chart snapshot here, and you can plainly see, the stock had been beaten back severely and is only just now beginning to mount a rebound.


Extended Watchlist:
DOLV, USRM, ICNB, ANW, CGG, ANTH

Blue Horseshoe Stocks: DLTR Recap & More

Dollar Tree, Inc. DLTR – Options Update

Yesterday turned out to be a nice bullish session for DLTR, making us glad we added it as a focus in our premarket report. No sooner than we updated our readers on the DLTR options ideas we submitted in last Wednesday‘s premarket report, did they take off to new highs once again.

The DLTR 04/21 $78-80 Calls had already provided us with double-bag gain chances, but yesterday’s activity pushed those figures a lot higher. The following numbers represent the maximum possible gains so far over the last six trading sessions:

$78 Calls – Range: .51-2.05 – Max Gain: 301%
$78.50 Calls – Range: .63-2.05 – Max Gain: 225%
$79 Calls – Range:  .48-1.43 – Max Gain: 198%
$79.50 Calls – Range: .35-1.40- Max Gain: 300%
$80 Calls – Range: .30-1.34 – Max Gain: 347%

We can continue to keep these contracts on our radar, with more than three weeks remaining until their expiration date.


Petroleo Brasiliero S.A. (Petrobras) PBR – Update

Another set of 04/21 options contracts that we’ve been tracking have also fared well, tacking on new highs yesterday,

We slated the PBR 04/21 $9.50 & $10 Calls for observation a week ago today, and must now swing back around to highlight the excellent moves these plays have made in a week’s time.

04/21 $9.50 Calls – Range: .18-.51 – Max Gain: 183%
04/21 $10 Calls – Range: .09-.27 – Max Gain: 200%

As stated on the above mentioned play, these contracts have more than three weeks before expiration, so we’ll continue to keep tracking their activity in coming sessions. Yesterday the stock closed just under the 200DMA of 9.69, and we’ll remain bullish on these ideas if the stock can break past that barrier.


Sphere 3D Corp. ANY

We want to make mention of ANY this morning after noticing a set of interesting circumstances. Just a few days following the closing of a $4.5M direct offering/ private placement, the company has now announced it has been awarded a $3M contract  (>>View PR)

All of this activity on the newsreel is happening concurrently with a potential reversal and rebound on the chart. The stock has been failing to satisfy its $1.00 minimum bid requirement for the better part of nine months now, and will need to get itself back above that mark or it could face delisting after just three years on the NASDAQ.


Extended Watchlist:
USRM, MMEX, DOLV, MYDX, GALT, EMKR, BCEI, VNCE,

Blue Horseshoe Stocks: Week Kicks Off on High Note


Yesterday, despite the fact that the markets as a whole were on pace for the longest sustained backslide in more than half a decade, we still managed to see new highs in a few of the stocks we’ve been tracking.  We also observed solid intraday performances from a couple other plays that were on our morning watchlist, so we’ll begin today with a quick roundup of all these movers.

Dolat Ventures, Inc. DOLV

We signaled our interest in tracking DOLV in Thursday’s report, and at the time we’d witness the stock trading at a low of .0056.

Yesterday concluded with a new high, and the recording of three straight bullish sessions since then, with DOLV trading in an intraday range from .0125 to .019, for a gain of 52% It brings the updated figure on the three session swing we’ve seen so far to an impressive 239%


MyDx, Inc. MYDX

We circled back to MYDX, a stock we’ve tracked all the way from a February low of .001, last Wednesday, while it was trading as low as .0077. It too has put together a multi-day run leading to impressive new highs once again yesterday.

The stock saw a daily range of .017-.0226, which represents an increase of 32% on the day, 193% from last Wednesday’s low, and a ridiculous 2160% from our witnessed low in February!


U.S. Stem Cell, Inc. USRM

Here’s another stock whose low (.014) came during the month of February, following our report on the 27th. We’ve been all over it since then , and in two sustained bursts it has absolutely soared.

After reminding our readers of that fact in yesterday’s premarket report, USRM managed to hit yet another new high for us. It traded from .07-.112 for a daily boost of 60% and the new high recorded pushed our overall observed gain on this play in just one months time to an even 700%


Honorable Mentions

We placed a couple of plays in yesterday’s extended watchlist that didn’t blow our minds by any stretch of the imagination, but did log some solid intraday increases that warrant continued observation for each of them.

Catalyst Pharmaceuticals, Inc. CPRX
Daily Range: 1.63-2.07 – Max Gain: 27%

Impax Laboratories, Inc. IPXL
Daily Range: 10.50-13.00 – Max Gain: 24%


Extended Watchlist:
BRSE, OWCP, CARA, NVIV, SHIP, SSH, SBLK